Dr. Charles Wade Taylor, MD

Dr. Taylor practices at Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma.

Dr. Taylor's NPI, 1003859679, was assigned on June 13, 2006. Dr. Taylor graduated from University of Oklahoma College of Medicine in 1982. Dr. Taylor holds Oklahoma license 14470.

Dr. Taylor's primary practice is Oklahoma Cancer Specialists and Research Institute, at 12697 E 51st S St, Tulsa, OK 74146 in Tulsa County. The practice phone is (918) 505-3200.

Dr. Taylor's primary practice is Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma. Dr. Taylor is also affiliated with Saint Francis Hospital. The medical group on file is Oklahoma Cancer Specialists and Research Institute. Dmand AI also links Dr. Taylor to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taylor practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Taylor's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Taylor's licenses on file in 2 states: Oklahoma and Arizona.

CMS data shows 141,392 Medicare services from Dr. Taylor across 84 procedure codes in 2024, for 1,276 Medicare patients. Medicare paid $2,006,405 for them.

CMS counts 1,276 Medicare patients who saw Dr. Taylor in 2024. The largest group is 65 to 74, with 596 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Taylor's median patient age at 71, with 71% women.

In 2024, Dr. Taylor wrote 2,323 Medicare Part D claims for 372 patients. 77% of them were for generic drugs. CMS names the drug for 2,153 of them, across 48 drugs with 11 or more claims each, at $5,302,043 in total drug cost. In 2023, CMS named 2,113 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Taylor for performance year 2024, reported individually. Dr. Taylor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Taylor, published from 2016 to 2017. Dr. Taylor's most frequent co-authors are Richy Agajanian, MD, Christopher S.r. Dakhil, MD and Ian Denison Schnadig, MD.

Dmand AI links Dr. Taylor to 1 clinical trial. Conditions studied include Neoplasm Metastasis and Neoplastic Processes.

CMS Open Payments shows 57 general payments to Dr. Taylor from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $467.

Dr. Taylor graduated from University of Oklahoma College of Medicine in 1982.